X4 Pharmaceuticals (XFOR) PEG Ratio
Market Cap: $34.96M
Avg Volume: 3.35M
Industry: Biotechnology
Sector: Healthcare
PEG Ratio Summary
- X4 Pharmaceuticals's trailing twelve month (TTM) PEG ratio is 0.01.
- X4 Pharmaceuticals's annual PEG ratio as of today is 0.06.
- X4 Pharmaceuticals's quarterly PEG ratio is -0.08.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess X4 Pharmaceuticals's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -3.94
- Quarterly: -0.93
- TTM: -1.08
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 57.68
- Quarterly: 102.86
- TTM: 13.67
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 6.66
- Quarterly: 6.66
- TTM: 1.83
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -1.13
- Quarterly: -4.47
- TTM: -0.31
These metrics provide insights into X4 Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
0.01
Annual PEG Ratio
0.06
Quarterly PEG Ratio
-0.08
X4 Pharmaceuticals Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
X4 Pharmaceuticals Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2024 | 0.06 | -3.94 | 57.68 | 6.66 | -1.13 |
| 2023 | 0.02 | -1.47 | 0.00 | 2.92 | -1.54 |
| 2022 | 0.01 | -0.67 | 0.00 | 0.85 | -0.82 |
| 2021 | -0.06 | -0.66 | 0.00 | 0.92 | -0.83 |
| 2020 | 0.06 | -2.08 | 43.03 | 1.77 | -2.19 |
| 2019 | 0.02 | -2.18 | 0.00 | 0.95 | -2.57 |
| 2018 | 0.03 | -0.15 | 1.83 | 0.30 | -0.16 |
| 2017 | 0.00 | -0.78 | 0.00 | 0.45 | -0.94 |
| 2016 | -0.05 | -3.40 | 0.00 | -1.38 | -3.61 |
| 2015 | 0.00 | -5.91 | 0.00 | -2.28 | -7.22 |
Related Metrics
Explore detailed financial metrics and analysis for XFOR.